Preemptive versus prophylactic approaches in the management of cytomegalovirus disease in solid organ transplant recipients: what we know and what we do not know.


Autoria(s): Meylan P.R.; Pascual M.
Data(s)

2006

Identificador

http://serval.unil.ch/?id=serval:BIB_12F41B137069

isbn:1537-6591

pmid:16941369

doi:10.1086/507338

isiid:000240253200012

Idioma(s)

en

Fonte

Clinical Infectious Diseases, vol. 43, no. 7, pp. 881-883

Palavras-Chave #Antiviral Agents/therapeutic use; Cytomegalovirus; Cytomegalovirus Infections/prevention & control; Ganciclovir/therapeutic use; Humans; Opportunistic Infections/prevention & control; Organ Transplantation/adverse effects; Preventive Medicine; Transplantation
Tipo

info:eu-repo/semantics/article

article